IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.960
AS - Asia 1.974
EU - Europa 1.844
SA - Sud America 690
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 47
OC - Oceania 2
AN - Antartide 1
Totale 7.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.802
SG - Singapore 1.005
RU - Federazione Russa 907
BR - Brasile 558
CN - Cina 355
IE - Irlanda 325
VN - Vietnam 312
SE - Svezia 199
IT - Italia 183
HK - Hong Kong 74
GB - Regno Unito 66
CA - Canada 55
IN - India 53
AR - Argentina 48
DE - Germania 48
BD - Bangladesh 35
ID - Indonesia 30
MX - Messico 29
EC - Ecuador 23
AT - Austria 18
CO - Colombia 17
PL - Polonia 16
JM - Giamaica 15
PY - Paraguay 14
TR - Turchia 14
IQ - Iraq 13
ZA - Sudafrica 13
UA - Ucraina 12
VE - Venezuela 11
FR - Francia 10
HN - Honduras 10
PK - Pakistan 10
ES - Italia 9
LT - Lituania 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
FI - Finlandia 7
IL - Israele 7
KE - Kenya 7
MA - Marocco 7
NI - Nicaragua 7
UY - Uruguay 7
PE - Perù 6
TN - Tunisia 6
BB - Barbados 5
BE - Belgio 5
KR - Corea 5
NL - Olanda 5
NP - Nepal 5
PR - Porto Rico 5
RO - Romania 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EE - Estonia 4
GT - Guatemala 4
JP - Giappone 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
TH - Thailandia 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GP - Guadalupe 2
IR - Iran 2
LB - Libano 2
MN - Mongolia 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GI - Gibilterra 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 7.516
Salva come PNG Salva come JPEG
Città #
Singapore 704
San Jose 418
Dublin 325
Princeton 172
Beijing 170
Ashburn 160
Santa Clara 145
Dallas 144
Council Bluffs 121
Ho Chi Minh City 114
Los Angeles 108
Altamura 90
Jacksonville 81
Hanoi 75
Hong Kong 69
Cave Creek 67
Wilmington 57
São Paulo 51
North Bergen 48
New York 40
Buffalo 34
Chicago 34
Redondo Beach 33
Rio de Janeiro 25
Chandler 23
Phoenix 22
Moscow 21
Nuremberg 19
The Dalles 17
Norwalk 16
Curitiba 15
Haiphong 15
London 15
Mexico City 15
Denver 14
Chennai 13
Montreal 13
Brooklyn 12
Dong Ket 12
Kansas City 11
Milan 11
Orem 11
St Louis 11
Frankfurt am Main 10
Guayaquil 10
Toronto 10
Atlanta 9
Boston 9
Manchester 9
Mumbai 9
San Francisco 9
Brasília 8
Las Vegas 8
Munich 8
Philadelphia 8
Porto Alegre 8
Warsaw 8
Belo Horizonte 7
Columbus 7
Johannesburg 7
Thái Bình 7
Vienna 7
Cleveland 6
Hangzhou 6
Istanbul 6
Kingston 6
Managua 6
Montevideo 6
Nairobi 6
Rome 6
San José 6
Santa Fe 6
Stockholm 6
Uberlândia 6
Bauru 5
Bridgetown 5
Brussels 5
Charlotte 5
Fortaleza 5
Guarulhos 5
Milwaukee 5
New Delhi 5
Phủ Lý 5
Richmond 5
Salvador 5
Seoul 5
Sorocaba 5
Ankara 4
Brno 4
Buenos Aires 4
Bắc Giang 4
Can Tho 4
Caracas 4
Chaguanas 4
Da Nang 4
Dhaka 4
Florence 4
Hefei 4
Helsinki 4
Hải Dương 4
Totale 3.918
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 860
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 166
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 150
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 125
Cellular pharmacology of gemcitabine 122
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 118
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 116
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 115
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 112
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 107
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 107
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 104
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 103
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 100
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 99
Natural compounds for cancer treatment and prevention 98
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 95
Druggable targets in pancreatic adenocarcinoma 94
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 92
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 90
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 90
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 89
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 89
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 87
Chronic inflammation in urothelial bladder cancer 86
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 85
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 85
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 84
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 84
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 83
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 83
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 82
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 82
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 82
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 81
Prognostic factors in primary and iterative surgery of colorectal liver metastases 81
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 81
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 80
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 80
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 80
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 79
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 79
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 79
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 79
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 79
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 78
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 78
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 78
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 76
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 76
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 75
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 75
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 75
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 74
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 74
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 74
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 73
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 73
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 72
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 71
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 71
Genomic and genetic alterations infuence the progression of gastric cancer 71
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 70
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 70
Pharmacological strategies for overcoming multidrug resistance 70
Size dependent biological profiles of PEGylated gold nanorods 69
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 68
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 67
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 66
Pharmacogenetics: Implementing personalized medicine 65
Role of ATP-binding cassette transporters in cancer initiation and progression 63
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 63
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 62
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 62
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 62
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 61
Emerging drugs in refractory colorectal cancer 61
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 60
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 59
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 58
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 56
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 53
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 52
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 52
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 51
Maintenance in gastric cancer: New life for an old issue? 51
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 47
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 45
Totale 7.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022204 0 0 0 0 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/20251.419 103 464 295 11 37 8 43 39 163 65 96 95
2025/20263.847 173 266 471 575 213 146 351 187 964 287 172 42
2026/20271.063 130 160 196 491 86 0 0 0 0 0 0 0
Totale 7.869